Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation

Nephrology Dialysis Transplantation

Volumn 19, Issue 10, 2004, Pages 2622-2629

  Montagnino, Giuseppe ^a   Banfi, Giovanni ^a   Campise, Maria Rosaria ^a   Passerini, Patrizia ^a   Aroldi, Adriana ^a   Cesana, Bruno Mario ^a   Ponticelli, Claudio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Anti rejection therapy variation; Chronic allograft nephropathy; Histology of chronic allograft nephropathy; Outcome assessment

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; CHRONIC DISEASE; CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 5444223443     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh453     Document Type: Article

References (20)

1. Meier-Kriesche HU, Ojo AO, Cibrik DM et al. Relationship of recipient age and development of chronic allograft failure. Transplantation 2000, 27; 70: 306-310
2. Seron D, Moreso F, Grinyo JM. Prevention and management of late renal allograft dysfunction. J Nephrol 2001; 14: 71-79
3. Furness PN. Histopathology of chronic renal allograft dysfunction. Transplantation 2001, 15; 71 [11 Suppl]: SS31-SS36
4. Racusen LC, Solez K, Colvin R. Fibrosis and atrophy in the renal allograft: interim report and new directions. Am J Transplant 2002; 2: 203-206
5. Monga G, Mazzucco G, Messina M, Motta M, Quaranta S, Novara R. Intertubular capillary changes in kidney allografts: a morphologic investigation on 61 renal specimens. Mod Pathol 1992; 5: 125-130
6. Isoniemi HM, Taskinen E, Hayry P. Histopathologic chronic damage index accurately predicts chronic renal allograft rejection. Transplantation 1994; 58: 1195-1198
7. Rush D, Nickerson P, Gough J et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 1998; 9: 2129-2134
8. Weir MR, Ward MT, Blahut SA et al. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. Kidney Int 2001; 59: 1567-1573
9. Di Maria L, Bertoni E, Rosati A et al. Mycophenolate mofetil (MMF) in the treatment of chronic renal rejection. Clin Nephrol 2000; 53: 33-34
10. Montagnino G, Tarantino A, Segoloni G et al. Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation. J Am Soc Nephrol 2001; 12: 2163-2169
11. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
12. Dunningan GM, Hammen JL, Harris TR. A SAS-IML program for implementing two-phase regression analysis of geophysical time series data. Comput Geosci 1997; 23: 763-770
13. DeVecchi A, Tarantino A, Montagnino G et al. Cyclosporine alone or combined with steroids in the treatment of cadaveric renal transplant recipients. Clin Transplant 1987; 1: 198-202
14. Tarantino A, Aroldi A, Stucchi L et al. A randomized prospective trial comparing cyclosporine monotherapy with triple drug therapy in renal transplantation. Transplantation 1991; 52: 53-57
15. Ponticelli C, Tarantino A, Montagnino G et al. A randomized trial comparing triple drug and double drug therapy in renal transplantation. Transplantation 1988; 45: 913 -918
16. Weir MR, Anderson L, Fink JC et al. A novel approach to the treatment of chronic allograft nephropathy. Transplantation 1997; 64: 1706-1710
17. Fink JC, Blahut SA, Weir MR. Optimal strategies for modeling the reciprocal of creatinine versus time in renal transplant recipients and patients with native chronic disease. Am J Kidney Dis 2002; 39: 753-761
18. Cosio FG, Frankel WL, Pelletier RP, Pesavento TE, Mitchell HL, Ferguson RM. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival. Am J Kidney Dis 1999; 34: 731-738
19. Hueso M, Bover J, Seron D et al. Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function. Transplantation 1998; 66: 1727-1731
20. Nankivell BJ, Fenton-Lee CA, Kuypers DRJ et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001; 71: 515-523